Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below

Benzinga14:02 ET

IGM Biosciences Refocuses Genzyme Collaboration on Immunology

TipRanksJul 5 16:28 ET

RBC Capital Maintains IGM Biosciences(IGMS.US) With Buy Rating, Maintains Target Price $20

RBC Capital analyst Brian Abrahams maintains $IGM Biosciences(IGMS.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 48.5% and

moomoo NewsJun 20 12:31 ET · Ratings

Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s (NASDAQ:IGMS) CEO Compensation For Now

Yahoo FinanceJun 5 07:26 ET

Will IGM Biosciences (NASDAQ:IGMS) Spend Its Cash Wisely?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed.

Simply Wall StJun 4 10:44 ET

IGM Biosciences to Present at the Jefferies Healthcare Conference

MOUNTAIN VIEW, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred

GlobeNewswireMay 29 07:00 ET